Security Efficacy COVID-19 Vaccination

CompletedOBSERVATIONAL

Enrollment

540

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

April 30, 2022

Conditions

Autoimmune StateSARS-CoV-2 Infection

Interventions

DIAGNOSTIC_TEST

Blood sampling

Detection of ANA, AMA, anti-dsDNA, anti-ENA, anti-MPO, anti-PR3, aPL, RF, ACPA, anti- TPO, anti-TG

Trial Locations (1)

Istituto Auxologico Italiano IRCCS, Milan

All Listed Sponsors

lead

Istituto Auxologico Italiano

OTHER

NCT05743361 - Security Efficacy COVID-19 Vaccination | Biotech Hunter | Biotech Hunter